NATUROPATHIC DOCTOR IN ONTARIO
Breast Cancer Screening in Ontario
What Every Woman Over 40 Should Know
Breast Cancer Screening in Ontario
If you are a woman over 40 in Ontario, chances are breast cancer screening has crossed your mind. Perhaps a reminder letter arrived in the mail. Perhaps a friend received a diagnosis. Perhaps you are wondering whether to start screening at 40 or wait until 50.
Let’s walk through what Ontario recommends and how that compares to national and international guidelines.
Breast cancer screening policy in Ontario has evolved significantly in recent years. As of 2026, the province has one of the more accessible screening frameworks in Canada, particularly for women in their forties and for those at elevated genetic risk.
Screening in Ontario is delivered through the Ontario Breast Screening Program (OBSP). Policies are divided into two main categories based on risk profile.
Breast Cancer Screening for Women at Average Risk in Ontario
Age 40 to 74: Self-Referral Mammograms Every 2 Years
In October 2024, Ontario expanded access by lowering the self-referral age.
Individuals aged 40 to 74 can self-refer for a mammogram every two years. No physician referral is required. This applies to average-risk individuals with no personal history of breast cancer and no acute breast symptoms.
Age 75 and Older: Physician Referral Required
Screening remains available every two years for individuals aged 75 and older, but a physician referral is required. Automatic reminder letters from the program stop at age 75.
Screening Modality
Digital mammography is the standard screening tool used across the program.
High-Risk Breast Cancer Screening in Ontario
Ontario has developed a comprehensive high-risk screening pathway for individuals aged 30 to 69 who meet specific criteria.
There are two entry categories.
Category A: Direct Entry into High-Risk Screening
Individuals can enter directly if at least one of the following applies:
Known carrier of a pathogenic or likely pathogenic gene variant such as BRCA1, BRCA2, TP53, or PALB2 (genetic test results must be submitted).
First-degree relative of a confirmed carrier who has had genetic counselling and declined testing.
Previously assessed as having a 25 percent or greater lifetime risk of breast cancer using validated tools such as IBIS or CanRisk. Documentation from a genetics clinic is required.
Prior therapeutic chest radiation before age 30, at least eight years ago (e.g., treatment for Hodgkin lymphoma).
Category B: Genetic Assessment Required
Individuals may require formal genetic counselling and possibly testing if they have:
A close blood relative with a known pathogenic variant associated with increased breast cancer risk.
Family patterns such as breast and ovarian cancer on the same side of the family, breast cancer diagnosed at age 35 or younger, invasive ovarian cancer, breast cancer in a person assigned male at birth, or Ashkenazi Jewish ancestry with breast or ovarian cancer.
Personal history features such as breast cancer diagnosed at age 45 or younger, triple-negative breast cancer at age 60 or younger, or early breast cancer with limited family structure.
If genetic assessment confirms a lifetime risk of 25 percent or greater or identifies a pathogenic variant, the individual may qualify for annual high-risk screening.
High-Risk Screening Protocol in Ontario
Annual screening with both mammography and breast MRI is recommended. If MRI is contraindicated, ultrasound may be used as an alternative.
This dual-modality approach increases sensitivity in younger and higher-risk populations, where breast tissue may be denser and cancers may develop more aggressively.
Eligibility Requirements for the Ontario Breast Screening Program
To be eligible for screening through the OBSP, individuals must:
Be an Ontario resident with a valid OHIP card.
Have no acute breast symptoms such as a new lump or nipple discharge. Symptomatic individuals require diagnostic imaging ordered by a clinician.
Have no personal history of breast cancer and no prior mastectomy.
If transfeminine, have used feminizing hormones for at least five consecutive years.
Ontario vs. Canadian Task Force Guidelines on Breast Cancer Screening
The primary policy tension in Canada exists between provincial implementation and recommendations from the Canadian Task Force on Preventive Health Care.
The Task Force’s 2024 draft guidance continues to recommend routine screening beginning at age 50 for women at average risk, with conditional or individualized screening between ages 40 and 49.
Key Differences Between Ontario and Federal Guidance
Start Age
Ontario supports self-referral beginning at age 40. The Canadian Task Force maintains 50 as the standard start age, with conditional recommendations in the forties.
Screening Frequency
Ontario recommends screening every two years from ages 40 to 74. The Task Force suggests intervals of every two to three years depending on age group.
Self-Referral Policy
Ontario permits self-referral from age 40, emphasizing informed choice and reducing the gatekeeping role of primary care referral. The Task Force does not explicitly endorse systematic screening in the 40 to 49 age group.
Dense Breasts
Ontario encourages awareness of breast density, though routine supplemental screening is not universally funded for average-risk individuals. The Task Force states that evidence supporting supplemental screening, such as ultrasound for dense breasts, remains of low certainty for reducing mortality, even though detection rates increase.
International Breast Cancer Screening Guidelines
Ontario’s decision to lower the start age to 40 aligns more closely with updated draft recommendations from the U.S. Preventive Services Task Force, which now support biennial screening beginning at age 40 for average-risk women.
This shift reflects emerging epidemiologic data showing a rise in early-onset breast cancer and evidence suggesting mortality reduction when screening begins earlier.
The Debate: Benefits vs. Harms of Screening in Your 40s
The Harms Argument
The Canadian Task Force has historically emphasized that screening women in their forties leads to higher rates of false positives, additional imaging, and biopsies. For every life saved, many women may experience short-term anxiety and unnecessary procedures.
The Benefits Argument
Advocacy groups and professional organizations such as Dense Breasts Canada and the Canadian Association of Radiologists argue that modern digital mammography is more accurate than older screening trials on which earlier guidelines were based. They emphasize that detecting cancer at Stage 1 rather than Stage 3 can significantly reduce the intensity of treatment, including the potential need for chemotherapy.
There is also recognition that some racialized populations, including Black, Hispanic, and Asian women, may experience peak incidence at younger ages, raising important equity considerations in screening policy.
From a public health perspective, Ontario’s approach reflects a prioritization of access and informed choice. The federal Task Force places greater weight on minimizing overdiagnosis and unnecessary intervention.
What Breast Cancer Screening Means for Women in Ontario
If you are 40 to 74 and at average risk, you can book a mammogram every two years without a referral.
If you have a strong family history, a known genetic mutation, or prior chest radiation at a young age, you may qualify for annual mammography and MRI through the High-Risk OBSP.
If you have new breast symptoms, screening is not the correct pathway. Diagnostic imaging ordered by a clinician is required.
Screening is about early detection, not prevention. It does not reduce risk, but it can reduce the stage at which cancer is found.
Ontario’s expanded access reflects a shift toward informed choice and earlier detection. National guidelines continue to weigh potential harms more heavily in younger women.
For women and families, the most practical step is to understand personal risk, review family history carefully, and discuss whether average-risk or high-risk screening applies.
Policy continues to evolve. Staying informed ensures that screening decisions are grounded in current evidence and aligned with individual values and health priorities.
Dr. Mariia Tanasyshyn, Naturopathic Doctor
Dr. Mariia Tanasyshyn, ND, is a licensed Naturopathic Doctor in Ontario with a rare and valuable dual background. Before completing her naturopathic medical training at the Canadian College of Naturopathic Medicine, Dr. Mariia earned her Doctor of Medicine (MD) degree in Ukraine, where she trained extensively in internal medicine. Although she is not practicing as a medical doctor in Ontario, her medical education provides a deep understanding of complex health conditions and allows her to interpret symptoms, labs, and diagnoses through a uniquely integrative lens.
Now fully licensed as a naturopathic doctor (ND) under the College of Naturopaths of Ontario (CONO), she offers evidence-informed, patient-centered care that blends the strengths of both medical and naturopathic approaches. Her visits are not covered by OHIP, but may be reimbursed through extended health insurance like other naturopathic services.
Dr. Mariia is passionate about helping patients feel heard, informed, and empowered. She prioritizes clear communication, shared decision-making, and creating personalized treatment plans that meet her patients where they are.
Patients often seek out Dr. Mariia when they are looking for health care answers and support. These patients often don’t have access to a family doctor, or they are receiving inadequate care from their GP.
Fluent in English, Ukrainian, and Polish, Dr. Mariia is committed to accessible, compassionate care for individuals and families across Ontario through secure virtual visits.
